ArticleAntibiotics (Basel, Switzerland)2021
Colistin Resistance and ESBL Production in
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Antimicrobial resistance in meat and meat products from Asia: An urgent one health challenge- a systematic review and meta-analysis.Poultry science · 2025Pooled it
- Whole-Genome Sequence Analysis of Colistin-Resistant,Antibiotics (Basel, Switzerland) · 2026Article
- Clonal and Plasmid-Mediated Dissemination of Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- Indoor airborne dust in veterinary facilities as a reservoir of bacterial pathogens and antimicrobial resistance.Frontiers in veterinary science · 2026Article
- Seasonal prevalence of extended-spectrum β-lactamase-producing bacteria in food-chain animals, humans, and the surrounding environment in Fayoum governorate: a one health approach.Frontiers in microbiology · 2026Article
- Integrated Genetic Characterization and Quantitative Risk Assessment of Cephalosporin- and Ciprofloxacin-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Bacterial Genomics for National Antimicrobial Resistance Surveillance in Cambodia.The Journal of infectious diseases · 2025Article
- Isolation of ESBL-ProducingMicroorganisms · 2025Article
- Isolation and Characterization of Colistin-ResistantMicroorganisms · 2025Article
- Article
- Article
- Mechanisms in colistin-resistant superbugs transmissible from veterinary, livestock and animal food products to humans.Iranian journal of veterinary research · 2025Review
- Phenotypic and Genomic Characterization of ESBL- and AmpC-β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2024Article
- Antimicrobial Susceptibility of CommensalAnimals : an open access journal from MDPI · 2024Article
- The Global Rise of ESBL-ProducingAnimals : an open access journal from MDPI · 2024Review
- Article
- Article
- Metagenomic insights into isolable bacterial communities and antimicrobial resistance in airborne dust from pig farms.Frontiers in veterinary science · 2024Article
- Clinical Characteristics, Antimicrobial Resistance, Virulence Genes and Multi-Locus Sequence Typing of Non-TyphoidalMicroorganisms · 2023Article
- Epidemiological study of antimicrobial-resistant bacteria in healthy free-ranging bantengs (Veterinary world · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
The study aimed to examine the prevalence and genetic characteristics of ESBL-production and colistin resistance in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.